DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response

As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, developme...

Source: Virology Journal - February 20, 2019 Category: Virology Authors: Ming Zhong, Huiqiang Wang, Linlin Ma, Haiyan Yan, Shuo Wu, Zhengyi Gu and Yuhuan Li Tags: Research Source Type: research